title: [Therapeutic approach for patients with positive resection line (R1) after gastrectomy for gastric cancer].
abstract: BACKGROUND
  The radical treatment of the gastric cancer consist in large gastric resections and lymphadenectomy. Resection line involvement at microscopic histopathological examination (R1) could change prognostic unfavorable.
  
  
  METHODS
  They were 135 patients with gastric cancer operated between 2006-2007, with radical gastric resections and lymphadenectomy. In 3 patients with early gastric cancer and 23 patients with different stages of cancers, histopathological examination showed resection line involvement. From this study were eliminated the patients with stage IV cancers in whom resections were palliative.
  
  
  RESULTS
  Incidence of positive resection line involvement was 19,25%. 88,46% of the tumors were staged pT2 and pT3 and the majority was poorly differentiated or undifferentiated (G3 and G4). Lymphatic involvement (pN1 or pN2) was demonstrated in 18 (69,23%0 patients with R1. Perioperative complications were encountered in 15,38% of this patients, with 7,69% mortality.
  
  
  CONCLUSIONS
  Presence of tumoral tissue at resection line level could decrease survival in this patients. Therapeutic protocol in patients with resection line involvement (re-laparotomy with re-resection or surveillance) must be establish in accordance with several factors: T and N category, risks of another surgical interventions, patients acceptance.
authors.affiliation: Spitalul Municipal Aiud, Cluj Napoca. ninanicolescu@yahoo.com
authors.forename: N
authors.initials: N
authors.lastname: Nicolescu
authors.forename: G
authors.initials: G
authors.lastname: Molnár
authors.forename: C
authors.initials: C
authors.lastname: Iancu
authors.forename: Hajjar N
authors.initials: HN
authors.lastname: Al
authors.forename: O
authors.initials: O
authors.lastname: Bălă
authors.forename: D
authors.initials: D
authors.lastname: Munteanu
authors.forename: L
authors.initials: L
authors.lastname: Vlad
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D015994:Incidence; D008197:Lymph Node Excision; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000601:surgery*; D011379:Prognosis; D012086:Reoperation; D012189:Retrospective Studies; D012307:Risk Factors; D012383:Romania / Q000453:epidemiology; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate; D016896:Treatment Outcome